- 充值
- 会员
- 职称材料
文献信息
Neurology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, covering neurological and psychiatric therapies, surgery and devices. The key features of the journal are: Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online. Open access: All articles published open access (CC-BY-NC) Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from pre-clinical, clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience. Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary. Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”). Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5500/ $6850/ £4700. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered. Contact: For more information about the journal, including pre-submission enquiries, please contact sumeyye.soydemir@springernature.com. Focuses on research around neurological and psychiatric therapies Rapid publication and personal point of contact throughout Maximum visibility with open access
Multiple SclerosisDisease-modifying TherapiesParkinson's DiseaseMild Cognitive ImpairmentDimethyl FumarateExpanded Disability Status ScaleNeuromyelitis Optica Spectrum DisorderCladribine TabletsQuality of LifeSpinal Muscular AtrophyMyasthenia GravisDisease ActivityCalcitonin Gene-Related PeptideChange from BaselineEpisodic MigraineHealth-related Quality of LifeGlatiramer AcetateTransthyretin AmyloidosisAcute Ischemic StrokeClinical Trials
vol.15 (2026)
vol.14 (2025)
vol.13 (2024)
vol.12 (2023)
vol.11 (2022)
vol.10 (2021)
vol.9 (2020)
vol.8 (2019)
vol.7 (2018)
vol.6 (2017)
vol.5 (2016)
vol.4 (2015)
vol.3 (2014)
vol.2 (2013)
vol.1 (2012)
Roberti, RobertaPoliti, CristinaAnzellotti, FrancescaBelcastro, VincenzoBeretta, SimoneBoero, GiovanniBonanni, PaoloCanafoglia, LauraD'Aniello, AlfredoDainese, FilippoDe Caro, CarmenDi Gennaro, GiancarloDi Giacomo, RobertaDiFrancesco, Jacopo C.Dono, FedeleFalcicchio, GiovanniFerlazzo, EdoardoFoschi, NicolettaGambardella, AntonioGiordano, AlfonsoLabate, AngeloLa Neve, AngelaLattanzi, SimonaLeggio, UgoLiguori, ClaudioMaschio, MartaMattioli, PietroNilo, AnnacarmenOperto, Francesca FeliciaPascarella, AngeloPauletto, GiadaPellegrino, LucianoRenna, RosariaRusso, EmilioDi Gennaro, GianfrancoCOMPARE Study Grp